vs
阿普塔集团（ATR）与Liberty Global Ltd.（LBTYA）财务数据对比。点击上方公司名可切换其他公司
Liberty Global Ltd.的季度营收约是阿普塔集团的1.3倍（$1.2B vs $962.7M），阿普塔集团净利率更高（7.7% vs -237.0%，领先244.7%），Liberty Global Ltd.同比增速更快（187.2% vs 13.5%），Liberty Global Ltd.自由现金流更多（$193.3M vs $96.9M），过去两年阿普塔集团的营收复合增速更高（2.6% vs -20.4%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
自由全球有限公司是一家英荷美合资的跨国电信企业，注册地位于百慕大，在伦敦、阿姆斯特丹和丹佛均设有总部。公司旗下拥有英国自由全球控股有限公司、荷兰自由全球有限公司及美国自由全球公司三大主体，其中英国主体为上市实体。企业由自由媒体国际业务部与UnitedGlobalCom于2005年合并成立，在全球电信服务领域拥有深厚的行业积累。
ATR vs LBTYA — 直观对比
营收规模更大
LBTYA
是对方的1.3倍
$962.7M
营收增速更快
LBTYA
高出173.7%
13.5%
净利率更高
ATR
高出244.7%
-237.0%
自由现金流更多
LBTYA
多$96.4M
$96.9M
两年增速更快
ATR
近两年复合增速
-20.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $1.2B |
| 净利润 | $74.3M | $-2.9B |
| 毛利率 | — | 66.8% |
| 营业利润率 | 11.0% | -8.6% |
| 净利率 | 7.7% | -237.0% |
| 营收同比 | 13.5% | 187.2% |
| 净利润同比 | -26.4% | -230.0% |
| 每股收益（稀释后） | $1.13 | $-8.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRLBTYA
| Q4 25 | $962.7M | $1.2B | ||
| Q3 25 | $961.1M | $1.2B | ||
| Q2 25 | $966.0M | $1.3B | ||
| Q1 25 | $887.3M | $1.2B | ||
| Q4 24 | $848.1M | $-1.4B | ||
| Q3 24 | $909.3M | $1.9B | ||
| Q2 24 | $910.1M | $1.9B | ||
| Q1 24 | $915.4M | $1.9B |
净利润ATRLBTYA
| Q4 25 | $74.3M | $-2.9B | ||
| Q3 25 | $127.9M | $-90.7M | ||
| Q2 25 | $111.7M | $-2.8B | ||
| Q1 25 | $78.8M | $-1.3B | ||
| Q4 24 | $100.9M | $2.2B | ||
| Q3 24 | $100.0M | $-1.4B | ||
| Q2 24 | $90.5M | $268.1M | ||
| Q1 24 | $83.1M | $510.0M |
毛利率ATRLBTYA
| Q4 25 | — | 66.8% | ||
| Q3 25 | — | 67.5% | ||
| Q2 25 | — | 63.3% | ||
| Q1 25 | — | 65.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 69.4% | ||
| Q2 24 | — | 68.5% | ||
| Q1 24 | — | 65.4% |
营业利润率ATRLBTYA
| Q4 25 | 11.0% | -8.6% | ||
| Q3 25 | 14.2% | -0.7% | ||
| Q2 25 | 14.9% | 2.3% | ||
| Q1 25 | 12.8% | 5.2% | ||
| Q4 24 | 14.2% | — | ||
| Q3 24 | 15.2% | 5.2% | ||
| Q2 24 | 13.8% | 1.0% | ||
| Q1 24 | 12.2% | 1.2% |
净利率ATRLBTYA
| Q4 25 | 7.7% | -237.0% | ||
| Q3 25 | 13.3% | -7.5% | ||
| Q2 25 | 11.6% | -220.1% | ||
| Q1 25 | 8.9% | -114.2% | ||
| Q4 24 | 11.9% | -158.9% | ||
| Q3 24 | 11.0% | -74.1% | ||
| Q2 24 | 9.9% | 14.3% | ||
| Q1 24 | 9.1% | 26.2% |
每股收益（稀释后）ATRLBTYA
| Q4 25 | $1.13 | $-8.66 | ||
| Q3 25 | $1.92 | $-0.27 | ||
| Q2 25 | $1.67 | $-8.09 | ||
| Q1 25 | $1.17 | $-3.84 | ||
| Q4 24 | $1.48 | $6.15 | ||
| Q3 24 | $1.48 | $-3.95 | ||
| Q2 24 | $1.34 | $0.71 | ||
| Q1 24 | $1.23 | $1.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $2.2B |
| 总债务越低越好 | $1.1B | $7.8B |
| 股东权益账面价值 | $2.7B | $9.7B |
| 总资产 | $5.3B | $22.6B |
| 负债/权益比越低杠杆越低 | 0.43× | 0.80× |
8季度趋势，按日历期对齐
现金及短期投资ATRLBTYA
| Q4 25 | $409.5M | $2.2B | ||
| Q3 25 | $264.8M | $1.7B | ||
| Q2 25 | $169.8M | $3.1B | ||
| Q1 25 | $136.8M | $2.0B | ||
| Q4 24 | $226.2M | $2.2B | ||
| Q3 24 | $327.9M | $3.3B | ||
| Q2 24 | $223.9M | $3.2B | ||
| Q1 24 | $201.1M | $2.8B |
总债务ATRLBTYA
| Q4 25 | $1.1B | $7.8B | ||
| Q3 25 | $546.0M | $7.8B | ||
| Q2 25 | $535.1M | $7.8B | ||
| Q1 25 | $561.2M | $8.2B | ||
| Q4 24 | $688.1M | $8.2B | ||
| Q3 24 | $822.7M | $14.9B | ||
| Q2 24 | $681.5M | $14.7B | ||
| Q1 24 | $680.4M | $14.8B |
股东权益ATRLBTYA
| Q4 25 | $2.7B | $9.7B | ||
| Q3 25 | $2.8B | $12.7B | ||
| Q2 25 | $2.7B | $13.0B | ||
| Q1 25 | $2.5B | $12.6B | ||
| Q4 24 | $2.5B | $12.4B | ||
| Q3 24 | $2.5B | $18.7B | ||
| Q2 24 | $2.4B | $18.3B | ||
| Q1 24 | $2.3B | $18.4B |
总资产ATRLBTYA
| Q4 25 | $5.3B | $22.6B | ||
| Q3 25 | $5.1B | $25.4B | ||
| Q2 25 | $4.9B | $27.2B | ||
| Q1 25 | $4.5B | $26.0B | ||
| Q4 24 | $4.4B | $25.4B | ||
| Q3 24 | $4.6B | $41.8B | ||
| Q2 24 | $4.5B | $40.8B | ||
| Q1 24 | $4.4B | $40.6B |
负债/权益比ATRLBTYA
| Q4 25 | 0.43× | 0.80× | ||
| Q3 25 | 0.20× | 0.61× | ||
| Q2 25 | 0.20× | 0.60× | ||
| Q1 25 | 0.22× | 0.65× | ||
| Q4 24 | 0.28× | 0.66× | ||
| Q3 24 | 0.32× | 0.80× | ||
| Q2 24 | 0.28× | 0.80× | ||
| Q1 24 | 0.29× | 0.80× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $630.9M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $193.3M |
| 自由现金流率自由现金流/营收 | 10.1% | 15.7% |
| 资本支出强度资本支出/营收 | 9.0% | 35.5% |
| 现金转化率经营现金流/净利润 | 2.47× | — |
| 过去12个月自由现金流最近4个季度 | $299.6M | $-132.0M |
8季度趋势，按日历期对齐
经营现金流ATRLBTYA
| Q4 25 | $183.7M | $630.9M | ||
| Q3 25 | $177.6M | $301.8M | ||
| Q2 25 | $126.0M | $149.2M | ||
| Q1 25 | $82.7M | $129.2M | ||
| Q4 24 | $178.2M | $791.6M | ||
| Q3 24 | $229.3M | $449.5M | ||
| Q2 24 | $143.6M | $546.1M | ||
| Q1 24 | $92.3M | $245.7M |
自由现金流ATRLBTYA
| Q4 25 | $96.9M | $193.3M | ||
| Q3 25 | $114.3M | $-41.1M | ||
| Q2 25 | $62.5M | $-170.1M | ||
| Q1 25 | $25.9M | $-114.1M | ||
| Q4 24 | $112.2M | $712.9M | ||
| Q3 24 | $162.7M | $102.4M | ||
| Q2 24 | $75.4M | $256.8M | ||
| Q1 24 | $16.7M | $-105.1M |
自由现金流率ATRLBTYA
| Q4 25 | 10.1% | 15.7% | ||
| Q3 25 | 11.9% | -3.4% | ||
| Q2 25 | 6.5% | -13.4% | ||
| Q1 25 | 2.9% | -9.7% | ||
| Q4 24 | 13.2% | -50.5% | ||
| Q3 24 | 17.9% | 5.3% | ||
| Q2 24 | 8.3% | 13.7% | ||
| Q1 24 | 1.8% | -5.4% |
资本支出强度ATRLBTYA
| Q4 25 | 9.0% | 35.5% | ||
| Q3 25 | 6.6% | 28.4% | ||
| Q2 25 | 6.6% | 25.2% | ||
| Q1 25 | 6.4% | 20.8% | ||
| Q4 24 | 7.8% | -5.6% | ||
| Q3 24 | 7.3% | 17.9% | ||
| Q2 24 | 7.5% | 15.4% | ||
| Q1 24 | 8.3% | 18.0% |
现金转化率ATRLBTYA
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | 0.35× | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | 2.04× | ||
| Q1 24 | 1.11× | 0.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
LBTYA
暂无分部数据
